When an expansive curlicue of tissue sitting below the ovaries was discovered more than a century ago, it was dismissed as useless and erased from biology textbooks. Biologists now are taking a new ...
Recent research sought to determine which patients with HR-positive breast cancer can benefit by adding ovarian function suppression to their adjuvant regimens, and which patients can skip it. A tumor ...
Ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHas) is a standard of care for premenopausal patients with high-risk stage II/III hormone receptor–positive breast ...
An ultrasound image of a human ovary that used shear wave elastography to assess ovarian stiffness by detecting and measuring fibrotic tissue. Medication to reduce ovarian scarring helps extends ...
A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...
The most accurate ultrasound test can detect 96% of ovarian cancers in postmenopausal women, new research suggests. The findings indicate that the test should replace the current standard of care test ...
University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...
Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...
This series was created for Google, the Buck Institute, Optispan and Phenome Health by Scientific American Custom Media, a division separate from the magazine’s board of editors. Women live far longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback